GNI Group Ltd banner

Intrinsic Value

The intrinsic value of GNI Group Ltd (GNIIF) under the Base Case is 11.28 USD per share. Compared with the current market price of 15.5 USD, the stock appears Overvalued by 27% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

GNIIF Intrinsic Value
$11.28
Overvaluation 27%
Intrinsic Value
Price $15.5

We don’t have enough historical valuation data to make this comparison.

Monitor GNIIF
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $9.03
Get notified when the price drops into your buy zone
Current Price $15.5
Intrinsic Value $11.28
Margin of Safety 20% $9.03
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to GNIIF

Fundamental Analysis

What GNI Group Does

Biotechnology Health Care

GNI Group Ltd is a Japanese biopharmaceutical company that discovers and develops new medicines, with a focus on hard-to-treat diseases such as fibrosis. Its work is centered on drug candidates rather than large-scale drug manufacturing, so the company acts mainly as a developer of potential therapies that can move through testing and, if successful, be licensed or commercialized with partners.

Headquarters
Japan JP
Employees
990
IPO date
Aug 31, 2007
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
GNI Group Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one GNIIF stock?

The intrinsic value for GNI Group Ltd (GNIIF) under the Base Case is 11.28 USD.

Is GNIIF stock undervalued or overvalued?

Compared with the current market price of 15.5 USD, the stock appears Overvalued by 27% .

Back to Top